Clinical Trial 55408

Winter Park, FL 32789


A Randomized, Multi-regional, Double-blind, Parallel-group, Placebo-controlled Phase 3 Study to Assess the Safety and Efficacy of 6 Months Treatment with Tigulixostat in Gout Patients with Hyperuricemia

Qualified Participants Must:

• 18-85 years old
• Have a diagnosis of gout

Qualified Participants May Receive:

  • Compensation for time and travel.

  • Study-related care at no cost. 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.